The First People's Hospital of Changzhou
π¨π³China
- Country
- π¨π³China
- Ownership
- Private
- Established
- 1918-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.czfph.com/en
Wingspan Stent System for Intracranial Artery Stenosis
Active, not recruiting
- Conditions
- Intracranial Artery StenosisStentEndovascular Therapy
- Interventions
- Device: Wingspan stent system
- First Posted Date
- 2024-09-30
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 53
- Registration Number
- NCT06618222
- Locations
- π¨π³
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
Regorafenib and Sintilimab in Combination With Electroacupuncture in MSS CRC
Not Applicable
Not yet recruiting
- Conditions
- Colorectal Cancer Metastatic
- Interventions
- First Posted Date
- 2024-06-13
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 40
- Registration Number
- NCT06456515
Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes
Phase 4
Not yet recruiting
- Conditions
- ObeseWeight LossPre-diabetes
- Interventions
- Drug: PlaceboDrug: Henagliflozin
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 300
- Registration Number
- NCT06216340
SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC
Phase 2
Not yet recruiting
- Conditions
- Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
- Interventions
- Radiation: SBRTDrug: Cadonilimab
- First Posted Date
- 2023-02-17
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 25
- Registration Number
- NCT05732662
SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
Phase 2
- Conditions
- Colorectal Neoplasm
- Interventions
- Drug: SOXDrug: XELOX
- First Posted Date
- 2016-08-17
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 60
- Registration Number
- NCT02870153
- Locations
- π¨π³
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
Microwave Ablation for Pulmonary Metastases From Colorectal Cancer
Not Applicable
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Device: microwave ablation
- First Posted Date
- 2015-07-20
- Last Posted Date
- 2016-08-15
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 32
- Registration Number
- NCT02502630
Cytokine-induced Killer Study for Patients With Stage II Melanoma
Phase 2
Not yet recruiting
- Conditions
- Melanoma
- Interventions
- Biological: Cytokine-induced killer cellsDrug: Ipilimumab
- First Posted Date
- 2015-07-15
- Last Posted Date
- 2015-07-15
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 300
- Registration Number
- NCT02498756
Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma
Phase 2
Not yet recruiting
- Conditions
- Lymphoma, Non-Hodgkin
- Interventions
- Biological: Cytokine-induced killer cells (CIK)
- First Posted Date
- 2015-07-15
- Last Posted Date
- 2015-07-15
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 1000
- Registration Number
- NCT02497898
Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer
Phase 1
Active, not recruiting
- Conditions
- Gastric Cancer
- Interventions
- Biological: CTL
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2016-02-22
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 60
- Registration Number
- NCT02496273
Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas
Phase 4
Not yet recruiting
- Conditions
- Cytokine-Induced Killer CellsAdvanced Milignant Gliomas
- Interventions
- Biological: CIKDrug: Temozolomide
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2015-07-14
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 120
- Registration Number
- NCT02496988
Β© Copyright 2025. All Rights Reserved by MedPath